drugset / Trial / NCT00483990
Phase I Study of PSD502 (Lidocaine Prilocaine Spray) Applied to the Glans Penis up to Three Times a Day for 21 Days in Healthy Male Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The main objective of the study is to determine the safety and tolerability of repeated application of PSD502 to the glans penis in healthy male volunteers
Timeline
- Start
- 2007-03
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PSD502 | Other / unclassified | — | Topical |
Indications
No indication recorded.